3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Ovarian Neoplasms
54
Breast Neoplasms
37
Fallopian Tube Neoplasms
22
Multiple Myeloma
19
Carcinoma, Ovarian Epithelial
15
Neoplasms
12
Lymphoma
10
Triple Negative Breast Neoplasms
7
Neoplasm Metastasis
6
Lymphoma, Large B-Cell, Diffuse
6
Recurrence
5
Hodgkin Disease
4
Breast Neoplasms, Male
4
Solid Tumors
3
Prostatic Neoplasms
3
Neoplasms, Plasma Cell
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large-Cell, Anaplastic
3
Burkitt Lymphoma
3
Sarcoma, Kaposi
2
Sarcoma
2
Peritoneal Neoplasms
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Follicular
2
Lymphoma, Extranodal NK-T-Cell
2
Lymphoma, B-Cell, Marginal Zone
2
Lung Neoplasms
2
Interventions
Echocardiography
2
liposomal doxorubicin
1
Vitamin E
1
Vitamin D
1
Tomography, X-Ray Computed
1
Tomography, Emission-Computed
1
Surveys and Questionnaires
1
Progestins
1
Positron-Emission Tomography
1
Nutrition Assessment
1
Methods
1
Mass Screening
1
Magnetic Resonance Imaging
1
Interviews as Topic
1
Immunomodulating Agents
1
Immune Checkpoint Inhibitors
1
Hormone Replacement Therapy
1
Hematologic Tests
1
Exercise Test
1
Estrogens
1
Estrogen Replacement Therapy
1
Educational Status
1
Dietary Supplements
1
Diet, Fat-Restricted
1
Calcium
1
Breathing Exercises
1
Blood Specimen Collection
1
Aspirin
1
Antineoplastic Agents
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Heart Diseases
×
liposomal doxorubicin
×
Clear all
NCT00563953
2017-10-12
CAPRICE
SOLTI Breast Cancer Research Group
Phase 2
Completed
50 enrolled